Phase 4 alcoholic fatty liver disease Clinical Trials
4 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–4 of 4 trials
Recruiting
Phase 4
Quantifying Hepatic Mitochondrial Fluxes in Humans
Non-Alcoholic Fatty Liver DiseaseType 2 DiabetesMitochondrial Metabolism Disorders
The University of Texas Health Science Center at San Antonio60 enrolled2 locationsNCT05305287
Recruiting
Phase 4
Fibrosis Lessens After Metabolic Surgery
Metabolic dysfunction-associated steatohepatitis (MASH)ObesityNon-Alcoholic Fatty Liver Disease+2 more
Ali Aminian120 enrolled22 locationsNCT06374875
Recruiting
Phase 4
Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD
Type2 Diabetes MellitusNonalcoholic Fatty Liver Disease
Zhujiang Hospital100 enrolled1 locationNCT06449833
Recruiting
Phase 4
Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT）
Chronic Hepatitis BNonalcoholic Fatty Liver Disease
First Affiliated Hospital of Wenzhou Medical University1,500 enrolled5 locationsNCT06368882